COVID-19; SARS-CoV-2; Biomarker Kinetics; Multi-organ involvement; Disease outcomes
SARS-CoV-2, Lipolysis-stimulated lipoprotein receptor, Angiotensin-converting enzyme 2, Free fatty acid, Primary human pneumocytes, Cytolysis, K18-hACE2 mouse